Sarcoma
8 competing products in clinical development for Sarcoma.
Pipeline by Phase
Pre-clinical1
Phase 1/21
Phase 25
Phase 31
All Products (8)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| cisplatin + doxorubicin hydrochloride + etoposide + ifosfamide + methotrexate + zoledronic acid | Chugai Pharmaceutical | Phase 3 | Active | 44 |
| Abemaciclib | Eli Lilly | Phase 2 | Active | 39 |
| exatecan mesylate | Daiichi Sankyo | Phase 2 | Completed | 35 |
| soblidotin | Daiichi Sankyo | Phase 2 | Completed | 35 |
| exatecan mesylate | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Fluzoparib+ Dalpiciclib | Sun Pharmaceutical | Phase 2 | UNKNOWN | 31 |
| Palonosetron - Single Dose + Palonosetron - Triple Dose + Adriamycin + Ifosfamide chemotherapy (AI) + Zinecard + Mesna + Vincristine + Dexamethasone | Eisai | Pre-clinical | Completed | 26 |
| PLX3397 + sirolimus | Daiichi Sankyo | Phase 1/2 | Terminated | 24 |